Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Make or break for Portugal in 2002?

This article was originally published in Clinica

Executive Summary

"2002 is going to be a very strange year" - and a strained one too for the Portuguese medical technology industry, from what Humberto Costa, chairman of leading association Apormed, tells Clinica. Indeed, the problems it faces go beyond issues such as funding, which has already led to apparently insurmountable arrears. For Apormed, the problems afflicting the country's device industry are deeply embedded in systemic, cultural failings of the entire healthcare system, which is in need of reform. As the country prepares for a national election, in which healthcare is set to top the agenda, Mr Costa hints at what he would like to see in the leading parties' manifestos.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064414

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel